Simple and complex forms of dysembryoplastic neuroepithelial tumors (DNTs) are readily recognizable but forms with diffuse growth pattern, and hybrid tumors, that is, mixed DNT and ganglioglioma (DNT/GG), are more contentious entities. Rare DNTs have shown aggressive behavior. We reviewed cortical growth patterns, immunophenotype (including CD34, nestin and calbindin), genetic profile, and outcome in 101 DNT in adults. Simple (n = 18), complex (n = 31), diffuse (n = 35) DNT, and mixed DNT/GG (n = 17) showed no difference in age of onset, associated seizure type, or outcome (67.5% free from seizure; mean follow-up, 6 years). CD34 was seen in 61%, calbindin in 57%, and nestin in 86% of all DNT types; these markers were less common in simple DNT. Peritumoral cortical changes (Layer I hypercellularity [61%], satellite nodules [51.6%]) were frequent, but dyslamination (cortical dysplasia) was not identified. Molecular genetic abnormalities identified in 17 cases were IDH1 mutation (n = 3), 1p/19q loss (n = 10), isolated loss 9q (n = 2), and PTEN loss (n = 3), which were not associated with tumor type or location, higher cell proliferation, or distinguishing clinical features (mean age of epilepsy onset, 9 years; age at surgery = 31 years; 69% free from seizure); none had progression on magnetic resonance imaging (mean follow-up, 6 years). No single feature was predictive of seizure-free outcome, but there was a trend for better outcome in CD34-positive tumors (p = 0.07). One case has shown transformation to a higher grade. This study supports the existence of a range of subtypes of DNT some with overlapping features with ganglioglioma; molecular genetic abnormalities were not predictive of atypical behavior.
INTRODUCTION
Dysembryoplastic neuroepithelial tumors (DNTs) were first delineated in 1988 (1), although they were recognized as slowly growing lesions associated with epilepsy in one of the earliest epilepsy surgical series (2) . They are included in the current World Health Organization (WHO) classification as low-grade glioneuronal tumors (3) , and more than 600 cases have now been reported in the literature. This increased documentation has highlighted several aspects of their diagnosis that remain contentious. The acceptance of a nonspecific DNT type, with a more diffuse growth pattern akin to more conventional gliomas, is not universal (3Y5). The lineage and histogenesis of the DNT tumor cell (the so-called oligodendroglia-like cell [OLC] ) remains poorly characterized. Cortical dysplasia associated with DNT is variably reported from 0% (6) to 70% to 80% (7, 8) , and its influence on seizures and outcome after resection remains unclear. There are emerging reports recognizing rare aggressive or recurrent behavior in DNT (9Y12). In addition, tumors with mixed features of DNT and other low-grade glial tumors, in particular ganglioglioma (13Y15), pilocytic astrocytoma (16) , and oligodendrogliomas (17) , have been reported. In light of the current literature, our aim was to define DNT subtypes in a large epilepsy series of 101 cases, based on conventional histologic features and to compare their immunohistochemical characteristics, molecular genetic profile, and clinical features including follow-up behavior.
MATERIALS AND METHODS

Patient Selection
Surgical resections carried out for the treatment of intractable focal epilepsy where a diagnosis of DNT was considered in the pathology report during the period 1992 to 2008 were identified from our hospital adult epilepsy surgery databases. A DNT was confirmed at postmortem examination in 1 patient who had a sudden unexpected death in epilepsy and had been investigated with magnetic resonance imaging (MRI) during life.
Clinical Data Collection
Clinical records were reviewed, and data were retrieved regarding patients epilepsy history (including age of onset and type of seizures), surgical treatment (age at surgery, operative procedure, extent of gross resection judged as complete or incomplete at surgery with or without a postoperative MRI), and outcome after surgery (including freedom from seizure, any further surgical procedures, and any evidence of tumor recurrence or regrowth of residual tumor).
Radiologic Features
The original MR images and/or computed tomographic scans where available were reviewed regarding the cortical location of the tumors and any characteristic features including T1 hypointensity, T2 hyperintensity, cystic change, calvarial expansion, calcification, in addition to the presence of any enhancement, white matter extension, diffuse borders, mass effect, hemorrhage, or atypical changes.
Histopathology and Immunohistochemistry
The histopathologic features of all tumors, adjacent cortex, and mesial temporal lobe structures where available were reviewed from the original stained sections, which included hematoxylin and eosin (H&E), Luxol fast blue/Cresyl violet, Alcian blue, Reticulin, Perls, and Masson Fontana stains. Immunohistochemistry was carried out on selected, representative 7-Km-thick sections for glial fibrillary acidic protein (GFAP) (polyclonal, 1:1500; DakoCytomation, Glostrup, Denmark), microtubule-associated protein 2 (MAP2) (monoclonal, 1:2000; Sigma, St Louis, MO), NeuN (monoclonal, 1:1500; Chemicon International, Temecula, CA), calbindin (polyclonal, 1:10,000; Swant, Marly, Switzerland), CD34 (monoclonal, 1:25; Dako), nestin (polyclonal, 1:8000; Chemicon), and Ki67 (monoclonal, 1:200; Dako) in most cases. In a proportion of cases, additional immunohistochemistry was carried out for parvalbumin (polyclonal, 1:6000; Swant), calretinin (polyclonal, 1:2000; Sigma), NogoA (polyclonal, 1:500; Chemicon), $-GFAP (polyclonal, 1:5000; Dako), synaptophysin (monoclonal, 1:100; Dako), and neurofilaments SMI31 (1:5000; Sternberger Monoclonals, Covance, Emeryville, CA), SMI32 (1:500; Sternberger Monoclonals), RT97 (monoclonal, 1:100; Novocastra, Leica Biosystems, Newcastle, UK), Pax6 (polyclonal, 1:50; Santa Cruz Biotechnology, Inc, Santa Cruz, CA), Map1b (monoclonal, 1:2500; Abcam, Cambridge, UK), doublecortin (monoclonal, 1:50; Abcam), and reelin protein (monoclonal, 1:1000; Chemicon). In brief, 7-Km-thick sections were dewaxed and rehydrated, endogenous peroxidase was quenched with 3% H 2 O 2 for 15 minutes, and sections were then microwaved in antigen retrieval buffer for 10 to 15 minutes. Sections then were incubated with the polyclonal or monoclonal antibodies. Sections were then incubated for 30 minutes with Dako Envision HRP detection system and visualized with Dako 3,3 ¶-diaminobenzidine. Between each step, sections were washed with phosphate-buffered saline and 0.05% Tween 20. Negative controls were treated identically except that the primary antibody was replaced with either normal mouse IgG or antibody diluents.
Double immunofluorescent labeling for CD34-nestin, CD34-GFAP, nestin-GFAP, and calbindin-CD34 was also carried out on selected cases. Sections were dewaxed and rehydrated, and endogenous peroxidase was blocked with 1% H 2 O 2 followed by microwave pretreatment in antigen retrieval buffer. Tissue sections were incubated with the first antibody, for example, polyclonal nestin antibody 1:8000 (Chemicon) for 1 hour, followed by incubation with Dako Envision HRP for 30 minutes. Sections were visualized with Cy3 using tyramide signal amplification plus fluorescence system (PerkinElmer LAS Ltd, Buckinghamshire, UK). For the second labeling, monoclonal antibodies were incubated overnight at 4-C, followed by goat anti-mouse Alexa Fluor (green fluorescent; Molecular Probes, Inc, Eugene, OR) for 2 hours and mounted with VECTASHIELD with 4 ¶,6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA). Sections were washed with phosphate-buffered saline between all steps. Sections were visualized with a Leica laser DMRB-SP2 (MP UV) confocal microscope.
Molecular Genetics
DNA was extracted from representative formalin-fixed, paraffin-embedded sections from the region of tumor showing maximal cellularity as identified on a reference H&E section. The sections were dewaxed and dried, and DNA extraction was carried out with MasterPure DNA Purification Kit (Epicentre; Illumina, Madison, WI). Analysis of copy number changes on chromosome 1p/19q, PTEN, and epidermal growth factor receptor was carried out using TaqMan copy number assay (Applied Biosystems, Warrington, UK). For analysis of IDH1 and IDH2 mutations, polymerase chain reaction amplification of the IDH1 gene (245-bp amplicon, FIGURE 1. Subtypes of dysembryoplastic neuroepithelial tumor (DNT). (A) Simple DNT composed of a specific GNE as demonstrated with NeuN immunostaining, which highlights the large neurons suspended in a matrix; intervening small, unstained oligodendroglia-like cells (OLC) are arranged in columns alongside capillaries. (B) Typical architecture of a complex DNT with multiple intracortical nodules at low-power extending throughout 2 gyri with Luxol fast blueYNissl (LFB/N) stain. (C) A diffuse DNT with an intracortical cellular infiltrate extending through a cortical gyral ribbon but lacking nodularity; there is underlying cystic cavitation of white matter (LFB/N). (D) Same case as in C showing overall hypercellularity of the cortex at low power in a Cresyl violetYstained section due to diffuse infiltration of OLC; the adjacent NeuN-immunostained section shows relative preservation of underlying cortical neuronal architecture between infiltrated cells. (E) Mixed DNT with aggregates of atypical ganglion cells elsewhere, the growth pattern resembles the glioneuronal element of a DNT (F). Scale bars = 10 mm (B, C); 1,000 Km (D); 100 Km (A, F); 80 Km (E). 
RESULTS
Tumor Subtypes
A total of 101 DNTs were categorized based on the current WHO classification (3) and available literature regarding their dominant growth pattern. Simple DNTs (18 cases) comprised mainly a specific glioneuronal element (GNE) (Fig. 1A) . Complex DNTs (31 cases) showed a multinodular/ nodular intracortical architecture (Fig. 1B) . Diffuse DNTs (35 cases) were characterized by diffuse cortical tumor infiltration and relatively sparse nodularity, myxoid matrix, or a distinct GNE (Figs. 1C, D) . Mixed tumors showed elements of both ganglioglioma and DNT with aggregates of atypical neurons or ganglion cells (Figs. 1E, F) . Cases with entrapped, hypertrophic cortical pyramidal neurons within the tumor were not judged as mixed DNTs. Included within the simple DNT category were 7 cases, comprising small samples only with limited adjacent cortex for evaluation.
The histologic features in each group are summarized in Table 1 . All were intracortical neoplasms characterized by OLC populations. The OLC displayed small nucleoli, fine chromatin, and ovoid to bean-shaped nuclei (Fig. 2A) ; multinucleation and focal degenerative pleomorphism ( Fig. 2A) were an occasional finding in all subtypes except the simple DNT (Table 1) ; mitotic activity was inconspicuous. Calcification was present in 28% of the DNT, and in a rare case, there was intratumoral ossification (Fig. 2B) . In addition to the defining and well-recognized features of DNT, less commonly reported growth patterns included focal perivascular rosette-like arrangement of cells (Fig. 2C) , palisades or alignment of nuclei, storiform patterns (Fig. 1D) , and areas with fibrillary zones reminiscent of subependymoma (Fig. 2E ). Fine intracellular pigment (variably Perls-or Masson FontanaY positive) was present in 51% and significantly more often in the complex and diffuse DNT (Table 1) . Neurofibrillary tangles within larger neurons were noted in 2 complex DNTs (patients aged 65 and 51 years at surgery), 1 simple DNT (patient aged 59 years), and 1 mixed tumor (patient aged 36 years) (Fig. 2F) . Spherical, intracortical eosinophilic, granular dendritic swellings (MAP2-positive, synaptophysin/neurofilament negative) were occasionally observed near the tumor (Fig. 2G ). Rarefaction of the underlying white matter was striking in 42% of DNT, with loss of myelin, gliosis, and microcavitation, which fell short of definite cystic change (Figs. 2H and 4A); this feature was less commonly observed in the simple subtype. Residual mature white matter neurons were typically visible within these rarefied regions.
Extension of the tumor into the underlying subcortical white matter and overlying meninges was noted in 49% and 36%, respectively; the former was significantly less common in the simple type (Table 1 ). An unusual finding was the presence of tumor ''bridges'' crossing sulci in 3 cases (Figs. 2I, J), with tumor extending into the normal cortex of the adjacent gyrus. Common cytoarchitectural features in the perilesional cortex, visible on H&E and often extending beyond the tumor into the next gyrus, included subpial and Layer I hypercellularity (62%) (Figs. 3A, B) and floccules of OLC and immature cells in the cortex and/or white matter forming small satellite nodules (51.4%) (Figs. 3D, E). The laminar cortical architecture often appeared distorted in H&E and Cresyl violet stains at the tumor border and infiltration zone, but no separate areas of dyslamination or distinct focal cortical dysplasia (FCD) were identified, and no balloon cells were seen.
The complete hippocampus was available for histologic examination in 30 cases. In some cases in which surgical resection of mesial temporal structures was performed ( Table 1) , limited tissue was available for accurate histologic assessment; these cases were not included in the evaluation. Evidence of hippocampal sclerosis was seen in 40%, with atypical patterns (end-folium sclerosis) predominating over classic hippocampal sclerosis (Table 1) . In 5 cases, the DNT was localized within mesial temporal structures (3 complex and 2 diffuse types), with extension to the entorhinal cortex in 4 cases, the alveus in 2 cases, and the amygdala in 2 cases, but without neocortical involvement. In all of these cases, there was striking satellitosis of CA1, subicular, and hilar pyramidal cells by OLC (Fig. 3G) ; this often imparted disorganization to the pyramidal cell layer. The OLC also merged with the subgranular zone of a dispersed granule cell layer (Fig. 3H ).
Neuroimaging Correlations
On MR images, 80% of the tumors were shown located in the temporal lobe, 16% in the frontal lobe, and the remainder in other cortical regions. There was no significant association between tumor location and DNT type ( Table 1) . Review of preoperative MRI was carried out in 46 cases. Common radiologic features included cystic change (23.9%), expansion of the overlying calvarium (19.5%), focal enhancement (19.5%), and calcification (15.2%). In 3 cases, the preoperative likely diagnosis was ''cavernoma.'' There was no Shown here are percentages of all DNT cases with specific expression patterns. *See text for details of cellular distribution of staining. DNT, dysembryoplastic neuroepithelial tumor; GFAP, glial fibrillary acidic protein; IHC, immunohistochemistry; MAP2, microtubule-associated protein 2; NS, no significant differences of labeling among the DNT subtypes (complex, simple, mixed, and diffuse); OLC, oligodendrocyte-like cells.
significant correlation between any radiologic feature and histologic tumor type.
Immunohistochemical Features
With our broad panel of antibodies for neuronal and glial differentiation, significant differences in tumor expression were noted between DNT types for CD34, calbindin, and nestin (p G 0.05) ( Tables 1 and 2 ). There was no significant difference of expression of these markers in relation to tumor location.
CD34 expression typically showed diffuse regions of labeling around OLC, imparting a honeycomb appearance and enhancing the multinodular architecture at low power (Figs. 4C, E). There was heterogeneity of staining within cases with positive and negative areas. Single multipolar cells with processes enwrapping neurons or extending to vessels were also observed; the latter feature was particularly prominent in regions of white matter rarefaction (Fig. 2H, inset) . Dysmorphic neurons were generally CD34-negative. In the perilesional cortex, CD34 labeling was observed in 64% of cases; common patterns included a CD34-positive band in the subpial/Layer I region (Fig. 3B) , labeling of small, satellite nodules in the cortex (Fig. 3E) , and white matter, perivascular labeling in rarefied white matter (Fig. 2H ) and (less often) a subcortical band of staining. CD34 staining corresponded with the Layer I hypercellularity and satellite nodules seen on H&E (Figs. 3A, D) . Tumor regions showing accumulation of extracellular Alcian blueYpositive matrix (including any GNE) were usually negative for CD34, except for the vascular endothelium. Therefore, only 25% of simple DNT were CD34-positive versus 82% in the diffuse DNT group. No significant differences in CD34 expression were evident regarding tumor localization, but all DNTs restricted to the mesial temporal structures were extensively CD34-positive.
Regional staining patterns within DNT for nestin were similar to those for CD34, although fewer cells appeared to be nestin-positive. Nestin-positive cells more often had a bipolar than multipolar morphology (Figs. 3C and 4F ). Dysmorphic or mature pyramidal neurons within the DNT did not express nestin. Labeling in Layer I in the adjacent cortex (Fig. 3C ) and peritumoral satellite nodules were noted, as for CD34. There was a positive correlation between nestin and CD34 expression (p G 0.01), and double labeling confirmed colocalization in OLC populations within individual DNT and the peritumoral cortex (Fig. 4I) ; nestin immunolabeling appeared more predominantly in the cores of the cellular processes compared with more peripheral cytoplasmic staining for CD34. Nestin and CD34 did not colocalize with GFAP-positive cells in any DNT (Fig. 4H ). Complex and diffuse DNTs more often showed nestin positivity.
Calbindin expression by DNT was noted more often for the mixed and diffuse types (p G 0.05) ( Table 1 ). The staining patterns included diffuse areas of synaptic-like staining (particularly striking in tumors that involved the parahippocampal gyrus) and single or nodular aggregates of OLC highlighting multipolar cells (Figs. 3F and 4B, F) . There was prominent labeling of dysmorphic neurons, either singly or extensively in nodules (Fig. 4B) . Calbindin-positive cells were noted as a component of tumors that extended into the ventricle and within leptomeninges; calbindin staining also highlighted a proportion of apparently entrapped, floating interneurons in the intracortical GNE. Calbindin expression by interneurons in the adjacent cortex appeared normal in 58%, reduced in 28%, or increased in 14%. This increased expression manifested as cells in Layer I and/or satellite nodules of multipolar cells in the perilesional cortex (Fig. 3F) . Calbindin positivity within an individual tumor did not precisely overlap with CD34 regional staining patterns (Figs. 4B, C); there was only occasional colocalization in individual tumor cells (Fig. 4J) , and there was no significant correlation between CD34 and calbindin tumor expression.
The OLCs were generally NeuN-negative (Table 2) , but entrapped and floating large neurons within nodules and the GNE were NeuN-positive, including those in tumors extending into the ventricle or overlying meninges. NeuN was primarily helpful in the assessment of cortical laminar architecture at the borders of the DNT and in the adjacent cortex. Where this appeared disorganized or depleted on conventional stains (H&E or Cresyl violet), particularly at tumor margins and infiltration zone, NeuN immunostaining confirmed that remnants of the 6-layered cortex, although overrun by tumor, retained overall normal orientation, neuronal maturation, and laminar order (Fig. 4D) . NeuN staining typically highlighted frequent, single, interstitial neurons in the regions of white matter rarefaction.
The OLCs were mainly negative for synaptophysin, neurofilament and MAP2 with only patchy labeling of OLC in a minority of cases (Table 2) . Of note, all simple DNTs showed focal MAP2-positive OLC. Glial fibrillary acidic protein and $-GFAP labeling highlighted scattered cells with astrocytic morphology within the DNT (Fig. 4G) , with more extensive labeling in regions with an astrocytic growth pattern. $-GFAP labeling also highlighted astrocytic cells in the subpial region. NogoA did not label OLC but did label occasional dysmorphic neurons in 4 mixed DNTs. The OLCs were also noted to be negative for doublecortin, reelin protein, Map1b, parvalbumin, and calretinin, with focal nuclear expression only for Pax6. Absence or reduction of parvalbuminpositive neurons was seen within 82% of the DNT extending into the adjacent cortex in 21% of cases. Similarly for calretinin, a reduction of labeled normal cortical interneurons was observed in the tumor region in 80% of cases and in 8% of cases in the adjacent cortex.
Clinical Correlations
Complex partial seizures were the most common seizure type overall and for all tumor, types with the exception of simple DNT cases in which secondary generalized seizures were more common ( Table 1 ). The mean age of onset of seizures was 14.6 years (range, 3 months to 54 years) and age at surgery was 30.5 years (range, 6Y65 years), with no significant difference among the DNT types (Table 1) . Only 2 patients in this series were operated on during childhood (aged 6 and 13 years), with subsequent operation for residual tumor in the first of these patients as an adult. The most In some series, cases were selected for by the presence of particular features, whereas other series included all DNT types with more varied morphologies. *Pediatric cases only. C indicates complex; D, diffuse DNT (which includes cases classified as ''nonspecific''); S, simple. †On the basis of descriptions in text and illustrations of cases. ‡Described feature based on imaging and not histologic description. §Cortical dysplasia has been reclassified according to Palmini criteria where there is sufficient description in the text.
''È'', described in a proportion of cases but number not specified; F, frontal; GNE, glioneuronal element; NOS, not otherwise specified; O, occipital; Ot, other localization including 1 or more lobe; P, parietal; T, temporal.
common surgical procedure was temporal lobectomy with removal of mesial structures in 42%, lobectomy in 20%, and lesionectomy in 38%. Gross total resection as assessed during surgery with or without postoperative imaging (but not by histologic evaluation) was considered to be achieved in 73%.
There was follow-up information available in 86 patients; in the remaining patients, either their medical records were not available or the patients were lost to follow-up, including 4 patients resident outside the United Kingdom. The mean period of postoperative follow-up was 6 years (range, 0.1Y18 years), with 83% of patients followed up at least up to 2 years. Overall, 67.5% had seizure-free outcomes (Engel Class I), with 20.5% Class II, and 12% Class III or worse.
There was no significant difference in outcomes in relation to tumor type; the most favorable outcome was in the diffuse DNT group with 84% of patients free from seizure (Table 1) . No factors were identified as predictive of a seizure-free outcome. There was a trend for CD34 expression to be associated with a more favorable outcome (p = 0.07); 70.6% of patients with a Class I outcome had CD34 tumor expression versus 56.2% with Class II and 28.6% with Class III outcomes. In 3 patients, seizures recurred postoperatively after seizure-free intervals of 8 to 10 years; in all of these cases, the initial surgical resection was not complete.
Seven patients in this cohort are now deceased (age at death 18Y65 years; mean, 41.4 years). Postmortem data were available in only 1 of these patients who had a sudden unexplained death in epilepsy before any planned surgery; neuropathologic examination excluded any changes within the tumor (e.g. mass effect, hemorrhage, transformation) as likely contributing to the immediate cause of death. One patient died at 1 month postoperatively from an unrelated infection. In the remainder, seizure outcomes of Class I were recorded in 3 patients (at 0.5, 3, and 3 years of follow-up), Class II in 1 patient (6 years of follow-up), and Class III in 1 patient (7 years of follow-up). Comorbid conditions of depression, schizophrenia, and memory decline were recorded in 3 patients, but information on the mode of death was not available.
More than 1 surgical procedure was carried out in 10 patients (3 complex, 2 simple, 2 diffuse, and 3 mixed DNT; with 2 resections in 7 patients and 3 resections in 3 patients). In 8 of the 10, the initial procedure was a partial resection; these tumors were located in the temporal lobe in 8 patients and frontal lobes in 2 patients. The main reasons for the second surgeries were to improve control of seizures and/or removal of residual tumor, with cystic degeneration noted in 1 case on follow-up MRI. The interval between the first and the most recent surgical procedure varied from 1 to 16 years (mean, 6.7 years). In 9 cases, histologic finding in the further specimens was also WHO Grade I. In 1 patient, progression in MRI corresponded to anaplastic tumor transformation of a previous complex WHO Grade I DNT (Fig. 5) . In this case, the initial presentation at age 12 with simple and complex partial seizures was followed by referral to an epilepsy surgical program later in adulthood after worsening of seizures. Temporal lobectomy with removal of the hippocampus was carried out at age 56 after MRI and EEG investigations. A complex DNT of the amygdala and involving the hippocampus, temporal neocortex, and extending into the ventricle, with associated hippocampal sclerosis, was confirmed (Figs. 5A, B) . The tumor showed a GNE, nodular aggregates, but was notable for numerous eosinophilic granular bodies, glomeruloid vessels, and a Ki67 index of up to 5% in areas, although mitotic figures were not conspicuous and no rosettes were present. CD34 was negative, but no 1p/19q loss, IDH1 or 2 mutation, or other molecular genetic abnormalities were identified. Initially, the patient was free from seizure for 2 years but was lost to follow-up and again presented at 3 years with a recurrence on the MR image (Fig. 5C ). Further surgery was carried out, and histology findings reported at another neurosurgical center revealed an anaplastic mixed glioneuronal tumor with a rosette-like pattern and focally high Ki67 index (Figs. 5DYG) .
Molecular Genetics
Seventy-three cases (10 simple, 21 complex, 29 diffuse, and 14 mixed DNT) were studied for molecular genetic abnormalities. Either the tissue was not available for study or the DNA was of insufficient quality for polymerase chain reaction amplification and sequencing in the remaining cases. Abnormalities were identified in 17 cases: IDH1 mutation in 3 cases (Fig. 6) , loss of heterozygosity (LOH) 1p/19q in 10 cases, isolated LOH 19q in 2 cases, and LOH 10q (PTEN locus) in 3 cases. One case had combined LOH 1p/19q and 10q. Neither epidermal growth factor receptor amplification nor IDH2 mutations were identified in any case. Dysembryoplastic neuroepithelial tumors with genetic abnormalities were not of a particular type or localization but had typical long seizure histories, with a mean age of onset of seizures at 8.9 years and age at surgery of 31.2 years ( Table 3 ). The tumors showed low mitotic or Ki67 proliferation rates and CD34 immunostaining was positive in 64% of cases. Follow-up data were available in 14 of the 17 cases (mean follow-up, 6 years). The tumors were only partially resected in 6 cases, but overall, 60% were free from seizure postoperatively (Engel Class I). There were no cases in this group with identified tumor progression or recurrence, although hemorrhage into the tumor was seen in 1 case on follow-up MRI.
DISCUSSION
This series supports the existence of a range of histologic subtypes of DNT in patients with drug-resistant partial epilepsy. Common features include predominant cortical localization, composition of OLC, low-grade histologic features, and a predilection for the temporal lobe. Dysembryoplastic neuroepithelial tumor subtypes included in the current WHO classification for CNS tumors are the simple and complex type (3). The nonspecific or diffuse DNT is a more controversial entity owing to the difficulty in distinguishing it from more conventional diffuse gliomas and its lack of the hallmark GNE and/or nodularity (5). We did not identify any clinical differences in the seizure history or outcome between diffusely growing and accepted DNT subtypes, as also noted in previous series (4, 18, 19) . Diffuse DNT accounted for 35% of tumors in our series compared with up to 28% in previous studies (Table 4) . Our studies also support the notion that, although GNE is a common growth pattern, it is not an absolute criterion for the diagnosis of DNT. In previously reported DNT series, GNE was noted in 73% of cases overall (Table 4) versus 59% of cases in the original series (1) . Atypical ganglion cells are also an occasional finding in DNT (Table 4) (1, 4) , and when they are prominent, ''hybrid'' tumors with mixed features of DNT and ganglioglioma have been diagnosed (13Y15, 20) . We grouped tumors with features of DNT but including aggregates of atypical neurons separately as ''mixed DNT.'' These also did not differ from other DNT subtypes with respect to clinical presentation and outcome; shared immunohistochemical expression patterns support a ganglioglioma/DNT glioneuronal tumor spectrum.
Immunohistochemistry is used to aid in discriminating DNT from other gliomas, as well as to explore cell lineage and maturity. The predominant cell type in DNT is termed oligodendroglia-like cell in recognition of its rounded nuclear profile, scant cytoplasm, and tendency to form clusters and satellite aggregates around neurons. These cells display more open chromatin, delicate nucleoli, and reniform shapes, suggesting an immature neuronal phenotype (2). In keeping with previous studies, we observed restricted expression of OLC for GFAP (4, 21Y23) and for conventional neuronal markers including synaptophysin and neurofilaments (4, 22) . Focal NeuN expression by OLC was observed in only 11% of cases compared with previous reports of 44% (24) . In contrast to astrocytomas and oligodendrogliomas, MAP2 expression in DNT has been reported to be restricted to the larger neuronal component, and relatively lacking in the OLC (25Y27). Similarly, we found that only half of all DNT showed focal expression of OLC with MAP2, and although not statistically significantly different among the subtypes, was observed in all simple DNT. CD34, calbindin, and nestin showed more consistent expression in DNT, highlighting OLC and their cellular processes. Calbindin expression was also consistently striking in the atypical neurons of mixed DNT. In CNS tumors, calbindin expression has been previously reported in a ganglioglioma (28) , in a proportion of subependymal giant cell astrocytomas (29) , and in medulloblastoma (30) ; this expression may reflect neuronal differentiation in these tumors. In our study, abnormal calbindin expression was noted in diffuse DNT significantly more than in simple or complex DNT (Table 1) . CD34 was also expressed less frequently in simple DNT, whereas positivity in mixed or diffuse DNT was similar to previous series of ganglioglioma of approximately 80% of cases (31) . CD34 is a glycophosphoprotein expressed by mature vascular endothelium and is also a marker of a subset of CNS stem cells (32) . CD34 expression in neoplastic and malformative glioneuronal lesions associated with chronic, focal epilepsy was first demonstrated by Blumcke et al (33) ; other glioma types less often show CD34 positivity. Although the nature of CD34-expressing immature cells is not fully characterized, previous studies have shown no colocalization with astrocytic or microglial markers but with neuronal markers and neurofilament gene transcripts (34) . In keeping with our observation of lower expression rates of CD34 in simple DNT, previous series reporting absent CD34 expression in DNT could be explained by selection of smaller numbers of cases comprising mainly a GNE (21, 33, 35) .
Nestin, an intermediate filament that was initially described in neural stem and progenitor cells in the developing CNS, was also noted in 86.4% of our DNT. A previous study showed greater nestin expression in diffuse type DNT, suggesting that this represents a more immature form of the tumor (36); focal coexpression of MAP2 and nestin had also been previously demonstrated in the OLC of DNT, suggesting that these cells are immature neuronal cells (27) . We have further confirmed overlapping expression and colocalization between nestin and CD34 in DNT. In contrast, less coexpression between CD34 and calbindin was observed and none between nestin and CD34 with GFAP. In addition, absent NogoA expression in DNT OLC is in contrast to the high expression in oligodendrogliomas (37) . These observations suggest that there are multiple immature cell types in DNT, with differentiation pathways in OLC overall favoring neuronal over astrocytic or oligodendroglial phenotype. Our working criteria for distinguishing diffuse and mixed DNT from other DNT types and low-grade gliomas are outlined in Table 5 .
Cortical dysplasia is frequently reported as an associated pathology in DNT, noted in 54% of cases in larger series (Table 4) (1, 4, 5, 7Y9, 18, 19, 21, 22, 38Y42) . However, there is marked variation in the reporting of dysplasia, from 0% to 70% to 80% of cases (6Y8). This could reflect differences in interpretation rather than real variability because the majority, based on description, corresponded to FCD Type I rather than Type II (43) ; there is known to be less interobserver diagnostic consistency for these entities (44) ( Table 4) . We reviewed perilesional cortical changes in our DNT series, and any impressions of cortical dyslamination in conventional stains were negated using NeuN immunohistochemistry, which confirmed overall preservation or residual 6-layered cortical architecture. This disparity between the lack of FCD Type I or II compared with previous DNT series could reflect the fact that our series is mainly adults; similar observations have been noted in another adult DNT series (6) . However, we consider it more likely that the application of NeuN immunohistochemistry allows a superior evaluation of cortical architecture by eliminating the tendency to interpret cortical disorganization in marginal tumor infiltration zones as dysplasia (5) .
In a recent reclassification of dysplasia in epilepsy, those associated with glioneuronal tumors have been segregated from isolated FCD (Types I and II) into a new category (FCD Type IIIB), acknowledging that the cause and diagnostic criteria for FCD Type IIIB require further evaluation (45) . In our series, hypercellularity in the subpial/Layer I region (in up to 82%) and small satellite tumor nodules (in up to 64.3%) in DNT subtypes overall were common peritumoral findings. It is arguable whether these histologic features represent the dysembryoplastic origins and precursor lesions from which the tumor arises or, alternatively, secondary tumor structures from local extension. The original theory proposed that DNT arose from the remnants of the secondary germinal layers, which includes the subpial granular layer (residual in normal infants in the temporal lobe and frontal lobe) and the dentate granule cell layer (1) . This may explain the observation of more common involvement of DNT in the temporal and frontal lobe (84% in the reported literature [ Table 4 ]; 96% in present series) which included 5 cases of DNT isolated to the hippocampus and centered on the dentate gyrus, as also previously noted (1, 21) . The common involvement of the leptomeninges (36% in our series and 27% in previous studies [ Table 4 ]) also supports origins in the superficial cortex or marginal zone. We did not identify the expression of a specific marker for subpial or superficial cortex progenitor cell populations or developmental proteins, despite evaluating $-GFAP, reelin, doublecortin, and Pax6 (46Y49). An additional striking feature in our series was the frequent hypomyelination and rarefaction of the underlying white matter in the vicinity of the tumor. This has been previously reported (4) and was observed in up to 54.3% of our cases, preferentially in the diffuse, mixed, and complex DNTs; this finding is not explained by tumor extension alone. It draws comparison with similar pathologic features seen in FCD Type IIB (45, 50) and may mimic FCD Type IIB on preoperative FLAIR MRI sequences (51) . This histologic feature could conceivably represent a developmental rather than acquired abnormality and part of the criteria for FCD Type IIIB; however, this requires further evaluation.
As noted by Daumas-Duport et al (5) , the acceptance of a diffuse or nonspecific form of DNT may increase the risk of overdiagnosing DNT, particularly with small samples. We undertook molecular genetic analysis to explore possible relationships or overlap between conventional gliomas and DNT. Ten cases with LOH 1p/19q were not clinically or pathologically distinct from other DNT; they represented all subtypes from varied locations including the temporal lobe and did not display more aggressive or recurrent behavior. Combined LOH 1p/19q is a frequent, early event in oligodendroglioma and is associated with less aggressive biologic behavior (52, 53) . Interestingly, LOH 1p/19q in oligodendroglioma has been associated with increased likelihood of presenting with seizures (54), whereas temporal lobe gliomas As such, histologic classification should remain the diagnostic standard at present. Mutations of the isocitrate dehydrogenase 1 or 2 gene (IDH1/2) have been reported in approximately 70% to 80% of astrocytomas, mixed gliomas, and oligodendrogliomas but are very rare in Grade I gliomas and are associated with better survival during tumor progression (60Y64). No IDH1/2 mutations were identified in a previous study of 4 DNT cases (62) ( Table 6 ). They were identified in only 3 DNT cases in the current series, suggesting an uncommon, but possible pathogenetic event. Of note, a strong association between LOH 1p/19q and IDH1/2 mutation has been shown in astrocytomas and oligodendrogliomas (64), which was not noted in our study.
There are 2 main outcome measures for the surgical treatment of DNT: successful control of seizures and removal of the tumor. Since the initial reports, DNTs have widely been regarded as indolent, quasi-hamartomatous lesions, with slow expansion on serial imaging. Cases with more accelerated growth have been long recognized (65) , with more recently emerging reports documenting regrowth of partially resected tumors and recurrence of tumors considered to be totally resected (Table 7) , most of these cases being extratemporal DNTs. In addition, transformation to a higher-grade lesion has been previously reported in 5 cases (Table 7) , with transformation into oligoastrocytoma Grade II, anaplastic astrocytoma, and glioblastoma (9Y12, 17). Ganglioglioma is a long-term epilepsy-associated tumor in which transformation of the glial component to anaplastic astrocytoma is an uncommon but acknowledged risk in 1% to 2% of cases with 7-to 8-year follow-up periods (31, 66, 67) . Higher rates of transformation in 17% of ganglioglioma were noted in 1 series where radiation treatment was given after the initial resection (68) . Of note, adjuvant treatment was also given before the transformation of 2 of the 5 reported malignant DNTs (10, 11) . In our series, transformation of a complex DNT to a higher-grade lesion occurred in only 1 case (1% of the series). This case was notable for a long preoperative seizure history, with partial resection and with a mixed glioneuronal phenotype in the recurrent anaplastic tumor. These cases highlight the misconception that tumor progression is never observed in DNTs and give credence to recommended longer follow-up periods in apparently cured patients with DNT, particularly with partial resections (38) and extratemporal DNT (Table 7) .
Previous studies report seizure-free outcomes after surgical treatment of DNTs in 82% of cases overall, with a range between 62% and 100% (Table 4 ). In our series, 67.5% of all cases were free from seizure, with up to 84% in the diffuse DNT cases. Variability in outcome among centers could reflect the length of the follow-up. Indeed, some (40, 51, 68) but not all (38, 69) series have recorded a decline in seizure control with longer follow-up periods, even in the absence of tumor recurrence (51) . We also noted 3 patients with recurrent seizures after long seizure-free intervals. Our operated series included mainly adults but comparisons with the published literature do not suggest marked differences in outcome between DNT operated in pediatric or adult age groups (83.6% versus 81% seizure-free respectively) ( Table 4) . Partial resection and the presence of residual tumor have been associated with continued or recurrent postoperative seizures (38, 40, 41, 51) ; these cases often require further resection (18, 70) , as in 9 cases in the present series. The presence or absence of coexisting cortical dysplasia (8, 18) , history of generalized seizures (19) , older age at surgery and longer duration of seizures (40, 41) , and an extratemporal location (38) have all been associated with worse seizure outcomes. In our series, we did not identify any significant prognostic factor, except for a trend for CD34 expression to be associated with a seizure-free outcome.
In summary, this study supports the existence of a range of DNT subtypes, with overlapping features with ganglioglioma and more consistent tumor expression patterns observed with immunohistochemistry for CD34, nestin, and calbindin, which may aid in the distinction of DNT from conventional gliomas. Typical FCD features were not identified using NeuN immunostaining, although distinctive peritumoral cortical changes were common and may represent changes within the spectrum of FCD Type III. The molecular genetic abnormalities identified were not predictive of atypical behavior. Malignant progression was observed in 1 case on follow-up with approximately two-thirds of patients becoming free from seizures after surgery.
